NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-03-31..
Operating margin
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -7.52M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | 131.07M USD | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $-7.52M | (m) | $131.07M | (m) | (m) | (m) |
| 2025-12-31 | $-5.61M | (m) | $122.91M | (m) | (m) | (m) |
| 2025-09-30 | $-6.54M | (m) | $123.01M | (m) | (m) | (m) |
| 2025-06-30 | $-8.66M | (m) | $120.57M | $1.80M | (m) | (m) |
| 2025-03-31 | $-9.24M | (m) | $118.31M | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $114.58M | (m) | (m) | (m) |
| 2024-09-30 | $-9.83M | (m) | $106.99M | (m) | (m) | (m) |
| 2024-06-30 | $-8.53M | (m) | $106.93M | $1.90M | (m) | (m) |
| 2024-03-31 | (m) | (m) | $109.56M | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | $117.67M | (m) | (m) | (m) |
| 2023-12-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $2.63M | (m) | $128.93M | (m) | (m) | (m) |
| 2023-06-30 | $4.71M | (m) | $135.86M | $2.10M | (m) | (m) |
| 2023-03-31 | $5.32M | (m) | $149.40M | (m) | (m) | (m) |
| 2022-12-31 | $11.08M | (m) | $153.05M | (m) | (m) | (m) |
| 2022-12-30 | $11.08M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $10.99M | (m) | $148.15M | (m) | (m) | (m) |
| 2022-06-30 | $13.68M | (m) | $140.46M | $2.50M | (m) | (m) |
| 2022-03-31 | $13.40M | (m) | $132.68M | (m) | (m) | (m) |
| 2021-12-31 | $12.82M | (m) | $137.19M | (m) | (m) | (m) |
| 2021-09-30 | $15.81M | (m) | $144.42M | (m) | (m) | (m) |
| 2021-06-30 | $13.67M | (m) | $148.08M | $1.90M | (m) | (m) |
| 2021-03-31 | $12.25M | (m) | $140.18M | (m) | $13.52M | (m) |
| 2020-12-31 | $5.33M | (m) | $123.28M | (m) | $16.50M | (m) |
| 2020-09-30 | $631.00K | (m) | $108.92M | (m) | $16.58M | (m) |
| 2020-06-30 | $-1.51M | (m) | $100.00M | $1.80M | $17.10M | (m) |
| 2020-03-31 | $-4.38M | (m) | $98.05M | (m) | $20.37M | (m) |
| 2019-12-31 | $1.67M | (m) | $104.59M | (m) | $17.75M | (m) |
| 2019-09-30 | $3.18M | (m) | $110.16M | (m) | $17.61M | (m) |
| 2019-06-30 | $5.96M | (m) | $114.72M | $1.80M | $17.61M | (m) |
| 2019-03-31 | $9.61M | (m) | $120.70M | (m) | $16.93M | (m) |
| 2018-12-31 | $10.30M | $143.60M | $116.68M | (m) | $16.63M | 7.17% |
| 2018-09-30 | $10.37M | $140.90M | $113.78M | (m) | $16.74M | 7.36% |
| 2018-06-30 | $9.53M | $132.44M | $106.12M | $1.50M | $16.79M | 7.20% |
| 2018-03-31 | $8.75M | $125.41M | (m) | (m) | $17.88M | 6.97% |
| 2017-12-31 | $7.22M | $118.73M | (m) | (m) | $17.82M | 6.08% |
| 2017-09-30 | $8.05M | $115.95M | (m) | (m) | $16.86M | 6.94% |
| 2017-06-30 | $9.70M | $121.95M | (m) | $1.60M | $16.50M | 7.96% |
| 2017-03-31 | $12.33M | $125.46M | (m) | (m) | $15.35M | 9.83% |
| 2016-12-31 | $14.44M | $130.33M | (m) | (m) | $14.58M | 11.08% |
| 2016-09-30 | $14.07M | $126.68M | (m) | (m) | $14.13M | 11.10% |
| 2016-06-30 | $12.26M | $114.20M | (m) | $1.10M | $13.00M | 10.73% |
| 2016-03-31 | $8.74M | (m) | (m) | (m) | $12.01M | (m) |
| 2015-12-31 | $6.67M | $90.69M | (m) | (m) | $11.29M | 7.36% |
| 2015-09-30 | $5.32M | $82.40M | (m) | (m) | $10.96M | 6.45% |
| 2015-06-30 | $4.16M | $79.51M | (m) | $1.10M | $10.18M | 5.23% |
| 2015-03-31 | $4.24M | (m) | (m) | (m) | $10.24M | (m) |
| 2014-12-31 | $4.37M | $77.63M | (m) | (m) | $9.88M | 5.63% |
| 2014-09-30 | $3.26M | $75.48M | (m) | (m) | $9.54M | 4.31% |
| 2014-06-30 | $2.78M | $73.94M | (m) | $948.00K | $9.96M | 3.76% |
| 2014-03-31 | $2.35M | $69.57M | (m) | (m) | $9.48M | 3.38% |
| 2013-12-31 | $1.75M | $66.28M | (m) | (m) | $9.50M | 2.64% |
| 2013-09-30 | $1.21M | $63.49M | (m) | (m) | $9.57M | 1.91% |
| 2013-06-30 | $2.15M | $62.80M | (m) | $1.20M | $9.60M | 3.43% |
| 2013-03-31 | $2.32M | $66.88M | (m) | (m) | $9.25M | 3.47% |
| 2012-12-31 | $3.38M | $68.47M | (m) | (m) | $9.54M | 4.94% |
| 2012-09-30 | $4.88M | $70.94M | (m) | (m) | $9.47M | 6.88% |
| 2012-06-30 | $6.20M | $72.82M | (m) | $1.10M | $9.25M | 8.51% |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $2.33M | $55.88M | (m) | $980.00K | $8.30M | 4.16% |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |